Marex Group PLC Adagene Inc. Put Options Transaction History

Marex Group PLC

  • $12.2 Billion
  • Q3 2025

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

About Adagene Inc.

ADAG Quotes by TradingView
  • Ticker ADAG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,423,200
  • Market Cap $80.8M
  • Description
  • Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...
More about ADAG
Track This Portfolio

Track Marex Group PLC Portfolio

Follow Marex Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marex Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Marex Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email